-
1دورية أكاديمية
المؤلفون: Alkis, O., Toktas, C., ZümrütbaÅŸ, Ali Ersin, Aybek, Zafer, Aybek, Hülya
مصطلحات موضوعية: biomarkers, brain derived neurotrophic factor, glycosaminoglycans, monocyte chemoattractant protein 1, nerve growth factor, overactive bladder, cre recombinase, Gag protein, monocyte chemotactic protein 1, solifenacin, biological marker, CCL2 protein, human, urinary tract agent, adult, Article, clinical article, controlled study, disease marker, disease severity, female, male, outcome assessment, postmenopause, prediction, premenopause, questionnaire, symptom, treatment duration, treatment response
العلاقة: Neurourology and Urodynamics; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11499/9112Test; https://doi.org/10.1002/nau.22939Test; 36; 390; 393; 2-s2.0-84953897806; WOS:000394667800027
-
2دورية أكاديمية
المؤلفون: Sebastianelli A., Spatafora P., Frizzi J., Saleh O., De Nunzio C., Tubaro A., Vignozzi L., Maggi M., Serni S., McVary K.T., Kaplan S.A., Gravas S., Chapple C., Gacci M.
المصدر: European Urology Focus ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073069312&doi=10.1016%2fj.euf.2019.09.015&partnerID=40&md5=15cbd991d2dcff76b7a6a906e03e2758Test
مصطلحات موضوعية: tadalafil, tamsulosin, alpha adrenergic receptor blocking agent, urinary tract agent, adult, aged, Article, backache, clinical article, combination drug therapy, drug safety, erectile dysfunction, headache, human, International Index of Erectile Function, International Prostate Symptom Score, lower urinary tract symptom, male, micturition, monotherapy, observational study, prostate hypertrophy, treatment outcome, treatment withdrawal, middle aged, prospective study, very elderly, Adrenergic alpha-Antagonists, 80 and over, Drug Therapy
-
3دورية أكاديمية
المؤلفون: Zachariou A., Filiponi M.
المصدر: International Braz J Urol ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027993537&doi=10.1590%2fS1677-5538.IBJU.2016.0303&partnerID=40&md5=62bf43db9b9569e285f2701c35209d9eTest
مصطلحات موضوعية: delayed release formulation, tolterodine, urinary tract agent, adult, drug effects, female, human, middle aged, prospective study, questionnaire, sexual behavior, Sexual Dysfunction, Physiological, Urinary Bladder, Overactive, young adult, Delayed-Action Preparations, Humans, Prospective Studies, Surveys and Questionnaires, Tolterodine Tartrate, Urological Agents, Brazilian Society of Urology
-
4
المؤلفون: Sebastianelli A., Spatafora P., Morselli S., Vignozzi L., Serni S., McVary K.T., Kaplan S., Gravas S., Chapple C., Gacci M.
المصدر: Current Urology Reports ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094197256&doi=10.1007%2fs11934-020-01009-7&partnerID=40&md5=c21d4f378ad650b579ae4193fb55ba94Test
مصطلحات موضوعية: placebo, tadalafil, tamsulosin, urinary tract agent, backache, bladder outlet obstruction index, Clinical Global Impression scale, combination drug therapy, dizziness, drug dose comparison, drug dose escalation, drug efficacy, drug safety, drug tolerability, drug withdrawal, dyspepsia, erectile dysfunction, headache, heartburn, human, hyperemia, hypotension, International Index of Erectile Function, International Prostate Symptom Score, lower urinary tract symptom, monotherapy, myalgia, nose obstruction, ocular hyperemia, postvoid residual urine volume
-
5
المؤلفون: Sakalis V.I., Karavitakis M., Bedretdinova D., Bach T., Bosch J.L.H.R., Gacci M., Gratzke C., Herrmann T.R., Madersbacher S., Mamoulakis C., Tikkinen K.A.O., Gravas S., Drake M.J.
المصدر: European Urology ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021831661&doi=10.1016%2fj.eururo.2017.06.010&partnerID=40&md5=f740d202bc426a66ef06c343f5696cf5Test
مصطلحات موضوعية: alpha 1 adrenergic receptor blocking agent, antidiuretic agent, beta 3 adrenergic receptor blocking agent, desmopressin, muscarinic receptor blocking agent, nonsteroid antiinflammatory agent, phosphodiesterase V inhibitor, placebo, sodium, steroid 5alpha reductase inhibitor, urinary tract agent, conservative treatment, disease severity, drug dose titration, human, hyponatremia, lower urinary tract symptom, male, monotherapy, nocturia, phytotherapy, practice guideline, priority journal, quality of life, randomized controlled trial (topic), Review, sodium blood level, systematic review, convalescence, pathophysiology
-
6
المؤلفون: Apostolidis A., Averbeck M.A., Sahai A., Rahmana'i S., Anding R., Robinson D., Gravas S., Dmochowski R.
المصدر: Neurourology and Urodynamics ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018699302&doi=10.1002%2fnau.23170&partnerID=40&md5=32794639e461614676d0f657c74b9770Test
مصطلحات موضوعية: beta 3 adrenergic receptor stimulating agent, botulinum toxin A, mirabegron, muscarinic receptor blocking agent, placebo, solifenacin, urinary tract agent, algorithm, bladder capacity, bladder reconstruction, clinical effectiveness, combination chemotherapy, drug choice, drug efficacy, drug preference, human, outcome assessment, overactive bladder, patient decision making, patient selection, randomized controlled trial (topic), Review, sacral nerve stimulation, treatment algorithm, bladder, drug effects, drug resistance, pathophysiology, Urinary Bladder, Overactive
-
7مراجعة
المؤلفون: Cao, X, Bian, J.-S
المساهمون: DEPT OF PHARMACOLOGY
المصدر: Unpaywall 20200831
مصطلحات موضوعية: 3 mercaptopyruvate sulfurtransferase, ap 39, cisplatin, cystathionine beta synthase, dextro amino acid oxidase, gyy 4137, hydrogen sulfide, losartan, propargylglycine, reactive oxygen metabolite, renin, sodium hydrosulfide, sodium sulfide, unclassified drug, urinary tract agent, acute kidney failure, chronic kidney disease, diabetic nephropathy, drug megadose, human, hypertension, hypertensive nephropathy, kidney disease, kidney dysfunction, kidney fibrosis, kidney ischemia, mitochondrion, nephrotoxicity, nonhuman, obstructive nephropathy
العلاقة: Cao, X, Bian, J.-S (2016). The role of hydrogen sulfide in renal system. Frontiers in Pharmacology 7 (OCT) : 385. ScholarBank@NUS Repository. https://doi.org/10.3389/fphar.2016.00385Test; https://scholarbank.nus.edu.sg/handle/10635/174247Test
-
8مورد إلكتروني
مصطلحات الفهرس: article, cell expansion, cell proliferation, cell protection, cell structure, controlled study, drug efficacy, drug mechanism, gene expression regulation, gene repression, gene silencing, genetic transfection, human, human cell, kidney hypertrophy/pc [Prevention], kidney proximal tubule, kidney tubule cell, kidney tubule damage/pc [Prevention], luciferase assay, male, mesangium cell, mouse, nonhuman, obstruction-induced renal fibrosis/pc [Prevention], polymerase chain reaction, priority journal, quantitative analysis, animal tissue, renal protection, reporter gene, signal transduction, streptozotocin-induced diabetes mellitus, upregulation, alpha smooth muscle actin/ec [Endogenous Compound], antifibrotic agent/dv [Drug Development], antifibrotic agent/pd [Pharmacology], beta actin/ec [Endogenous Compound], collagen type 1/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], locked nucleic acid, messenger RNA/ec [Endogenous Compound], microRNA/dv [Drug Development], microRNA/ec [Endogenous Compound], microRNA/pd [Pharmacology], mitogen activated protein kinase 1/ec [Endogenous Compound], recombinant transforming growth factor beta1, selumetinib/dv [Drug Development], selumetinib/pd [Pharmacology], Smad3 protein/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dv [Drug Development], urinary tract agent/pd [Pharmacology], microRNA 378/dv [Drug Development], microRNA 378/ec [Endogenous Compound], microRNA 378/pd [Pharmacology], rat, animal model, animal experiment, animal cell, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39470Test
Clinical Science
Click here for full text options
LibKey Link -
9مورد إلكتروني
مصطلحات الفهرس: article, cell expansion, cell proliferation, cell protection, cell structure, controlled study, drug efficacy, drug mechanism, gene expression regulation, gene repression, gene silencing, genetic transfection, human, human cell, kidney hypertrophy/pc [Prevention], kidney proximal tubule, kidney tubule cell, kidney tubule damage/pc [Prevention], luciferase assay, male, mesangium cell, mouse, nonhuman, obstruction-induced renal fibrosis/pc [Prevention], polymerase chain reaction, priority journal, quantitative analysis, animal tissue, renal protection, reporter gene, signal transduction, streptozotocin-induced diabetes mellitus, upregulation, alpha smooth muscle actin/ec [Endogenous Compound], antifibrotic agent/dv [Drug Development], antifibrotic agent/pd [Pharmacology], beta actin/ec [Endogenous Compound], collagen type 1/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], locked nucleic acid, messenger RNA/ec [Endogenous Compound], microRNA/dv [Drug Development], microRNA/ec [Endogenous Compound], microRNA/pd [Pharmacology], mitogen activated protein kinase 1/ec [Endogenous Compound], recombinant transforming growth factor beta1, selumetinib/dv [Drug Development], selumetinib/pd [Pharmacology], Smad3 protein/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dv [Drug Development], urinary tract agent/pd [Pharmacology], microRNA 378/dv [Drug Development], microRNA 378/ec [Endogenous Compound], microRNA 378/pd [Pharmacology], rat, animal model, animal experiment, animal cell, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39470Test
Clinical Science
Click here for full text options
LibKey Link -
10مورد إلكتروني
مصطلحات الفهرس: insulin dependent diabetes mellitus, macrophage, male, mouse, nonhuman, podocyte, priority journal, renal protection, signal transduction, systolic blood pressure, albumin/ec [Endogenous Compound], apoptosis signal regulating kinase 1/ec [Endogenous Compound], CD6 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], kidney injury molecule 1/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], plasminogen activator inhibitor 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/po [Oral Drug Administration], protein serine threonine kinase inhibitor/pd [Pharmacology], RNA/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dt [Drug Therapy], urinary tract agent/po [Oral Drug Administration], urinary tract agent/pd [Pharmacology], WT1 protein/ec [Endogenous Compound], gs 444217/dt [Drug Therapy], gs 444217/po [Oral Drug Administration], gs 444217/pd [Pharmacology], albuminuria, animal cell, animal experiment, animal model, animal tissue, article, cell loss, controlled study, diabetic nephropathy/dt [Drug Therapy], disease course, early intervention, enzyme inhibition, glomerulosclerosis, glucose blood level, hypertension, IC50, in vitro study, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/41052Test
Diabetes
Click here for full text options
LibKey Link